Clinical Trials Directory

Trials / Completed

CompletedNCT00862355

Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Sun Pharma Advanced Research Company Limited · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bioequivalence study of SPARC147609

Conditions

Interventions

TypeNameDescription
DRUGSPARC147609IV infusion
DRUGReference147609IV infusion

Timeline

Start date
2010-03-01
Primary completion
2010-12-01
Completion
2011-01-01
First posted
2009-03-16
Last updated
2019-05-03

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT00862355. Inclusion in this directory is not an endorsement.